Please provide your email address to receive an email when new articles are posted on . A retrospective claims analysis included more than 184,000 individuals with migraine who used at least one ...

Migraine affects many individuals worldwide, yet many patients remain undiagnosed or undertreated, highlighting a widespread, unmet need that calls for new drugs and pathways for migraine treatment.

The risk of autism disorders was slightly, but not significantly, elevated with both triptan late discontinuation trajectories. (HealthDay News) — Children prenatally exposed to different triptan ...

October 13, 2011 (San Diego, California) — More than 20% of patients with migraine who also have cardiac contraindications continue to take triptans despite warnings, a new study shows. "It is ...

Please provide your email address to receive an email when new articles are posted on . Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ...

Insufficient response to triptans is associated with poor health-related quality of life and lower work productivity in migraineurs compared with those who respond well to the medications, according ...

June 18, 2007 (Chicago) -- During a migraine attack, physicians stress the importance of taking triptans early to achieve optimal efficacy. Results of a new study, however, indicate that 42% of ...

Oct. 11 (UPI) --A class of drugs called triptans remains the most effective treatment for migraines, an analysis of data from more than 60 studies published Monday by JAMA Network Open found. Adults ...

Triptan class of drugs are more effective in treating migraine headaches, compared to newer and more expensive drugs, an analysis of nearly 140 clinical trials, involving about 90,000 participants, ...

Triptans have been a go-to acute migraine treatment for decades, and for many people these tried-and-true medications reliably keep full-blown migraine attacks at bay. But that’s not the case for ...